Telix Historical Financial Ratios

TLX Stock

14.70 0.07 0.47%

Telix Pharmaceuticals is promptly reporting on over 54 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.0, Capex To Depreciation of 0.18, ROIC of 0.18 or Inventory Turnover of 9.24 will help investors to properly organize and evaluate Telix Pharmaceuticals financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Telix Financial Ratios Analysis

Telix PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Telix Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Telix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Telix Pharmaceuticals history.

Telix Pharmaceuticals Financial Ratios Chart

At this time, Telix Pharmaceuticals' Intangibles To Total Assets are fairly stable compared to the past year. Debt To Equity is likely to rise to 0.12 in 2024, whereas Price To Sales Ratio is likely to drop 0.41 in 2024.

Days Sales Outstanding Average Payables Capex To Depreciation Inventory Turnover Days Of Inventory On Hand Roe

Add Fundamental

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from Telix Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Payables Turnover	0.21	3.66	5.73	11.12
Days Of Inventory On Hand	494.78	50.26	33.58	67.13

Payables Turnover Days Of Inventory On Hand

Telix Pharmaceuticals fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		-0.37	-0.32	0.3	0.77	0.65	0.07	-0.37	0.86	0.59	-0.48	0.64	0.21	-0.33	0.37	-0.27	-0.21	-0.85	0.17	-0.36	-0.75	-0.34	-0.55	0.29	-0.84	-0.53
Ptb Ratio	-0.37		0.13	-0.13	-0.31	-0.07	0.06	1.0	-0.32	-0.07	-0.02	-0.13	-0.09	0.13	-0.16	0.14	0.11	0.11	-0.07	0.03	0.12	0.14	0.05	-0.37	0.1	0.31
Days Sales Outstanding	-0.32	0.13		0.11	-0.39	-0.36	0.15	0.13	-0.6	-0.35	-0.43	-0.61	0.09	0.89	-0.57	0.84	-0.17	0.22	-0.64	0.1	0.18	1.0	0.49	-0.81	0.23	0.19
Book Value Per Share	0.3	-0.13	0.11		0.25	0.2	0.17	-0.13	0.14	0.2	-0.26	0.06	0.85	0.06	0.01	0.16	-0.91	-0.08	-0.15	-0.06	-0.01	0.08	0.29	-0.08	-0.07	-0.18
Free Cash Flow Yield	0.77	-0.31	-0.39	0.25		0.95	-0.15	-0.31	0.73	0.93	-0.11	0.55	0.31	-0.37	0.7	-0.39	-0.17	-0.54	0.23	-0.23	-0.44	-0.41	-0.77	0.31	-0.54	-0.46
Operating Cash Flow Per Share	0.65	-0.07	-0.36	0.2	0.95		-0.12	-0.07	0.64	0.97	-0.11	0.53	0.25	-0.34	0.72	-0.36	-0.08	-0.48	0.26	-0.23	-0.34	-0.38	-0.81	0.23	-0.48	-0.44
Capex To Depreciation	0.07	0.06	0.15	0.17	-0.15	-0.12		0.06	-0.02	-0.34	0.03	-0.27	0.12	0.13	-0.35	0.45	-0.2	-0.17	-0.02	-0.9	0.09	0.15	0.36	-0.12	-0.17	-0.73
Pb Ratio	-0.37	1.0	0.13	-0.13	-0.31	-0.07	0.06		-0.32	-0.07	-0.02	-0.13	-0.09	0.13	-0.16	0.14	0.11	0.11	-0.07	0.03	0.12	0.14	0.05	-0.37	0.1	0.31
Ev To Sales	0.86	-0.32	-0.6	0.14	0.73	0.64	-0.02	-0.32		0.59	-0.31	0.69	0.09	-0.4	0.53	-0.37	-0.06	-0.71	0.58	-0.3	-0.62	-0.6	-0.63	0.31	-0.71	-0.47
Free Cash Flow Per Share	0.59	-0.07	-0.35	0.2	0.93	0.97	-0.34	-0.07	0.59		-0.13	0.57	0.27	-0.34	0.77	-0.42	-0.09	-0.41	0.23	0.01	-0.35	-0.37	-0.81	0.23	-0.41	-0.23
Roic	-0.48	-0.02	-0.43	-0.26	-0.11	-0.11	0.03	-0.02	-0.31	-0.13		-0.23	-0.05	-0.47	0.13	-0.43	0.15	0.52	0.09	-0.06	0.54	-0.43	0.04	0.51	0.52	0.03
Inventory Turnover	0.64	-0.13	-0.61	0.06	0.55	0.53	-0.27	-0.13	0.69	0.57	-0.23		0.12	-0.62	0.71	-0.6	-0.02	-0.71	0.47	0.0	-0.73	-0.63	-0.51	0.5	-0.71	-0.15
Net Income Per Share	0.21	-0.09	0.09	0.85	0.31	0.25	0.12	-0.09	0.09	0.27	-0.05	0.12		0.02	0.19	0.13	-0.86	-0.06	-0.2	-0.07	-0.03	0.06	0.24	-0.09	-0.05	-0.07
Days Of Inventory On Hand	-0.33	0.13	0.89	0.06	-0.37	-0.34	0.13	0.13	-0.4	-0.34	-0.47	-0.62	0.02		-0.5	0.91	-0.1	0.26	-0.31	0.08	0.23	0.91	0.42	-0.95	0.26	0.17
Payables Turnover	0.37	-0.16	-0.57	0.01	0.7	0.72	-0.35	-0.16	0.53	0.77	0.13	0.71	0.19	-0.5		-0.57	-0.01	-0.38	0.56	0.04	-0.38	-0.58	-0.58	0.44	-0.38	-0.17
Capex To Revenue	-0.27	0.14	0.84	0.16	-0.39	-0.36	0.45	0.14	-0.37	-0.42	-0.43	-0.6	0.13	0.91	-0.57		-0.22	0.16	-0.33	-0.21	0.21	0.85	0.55	-0.88	0.16	-0.07
Cash Per Share	-0.21	0.11	-0.17	-0.91	-0.17	-0.08	-0.2	0.11	-0.06	-0.09	0.15	-0.02	-0.86	-0.1	-0.01	-0.22		0.13	0.18	0.1	0.12	-0.13	-0.43	0.11	0.12	0.14
Pocfratio	-0.85	0.11	0.22	-0.08	-0.54	-0.48	-0.17	0.11	-0.71	-0.41	0.52	-0.71	-0.06	0.26	-0.38	0.16	0.13		-0.2	0.42	0.94	0.24	0.38	-0.18	1.0	0.47
Interest Coverage	0.17	-0.07	-0.64	-0.15	0.23	0.26	-0.02	-0.07	0.58	0.23	0.09	0.47	-0.2	-0.31	0.56	-0.33	0.18	-0.2		-0.17	-0.13	-0.61	-0.32	0.24	-0.2	-0.29
Capex To Operating Cash Flow	-0.36	0.03	0.1	-0.06	-0.23	-0.23	-0.9	0.03	-0.3	0.01	-0.06	0.0	-0.07	0.08	0.04	-0.21	0.1	0.42	-0.17		0.14	0.1	0.03	-0.06	0.42	0.89
Pfcf Ratio	-0.75	0.12	0.18	-0.01	-0.44	-0.34	0.09	0.12	-0.62	-0.35	0.54	-0.73	-0.03	0.23	-0.38	0.21	0.12	0.94	-0.13	0.14		0.2	0.32	-0.16	0.94	0.19
Days Payables Outstanding	-0.34	0.14	1.0	0.08	-0.41	-0.38	0.15	0.14	-0.6	-0.37	-0.43	-0.63	0.06	0.91	-0.58	0.85	-0.13	0.24	-0.61	0.1	0.2		0.48	-0.83	0.24	0.2
Income Quality	-0.55	0.05	0.49	0.29	-0.77	-0.81	0.36	0.05	-0.63	-0.81	0.04	-0.51	0.24	0.42	-0.58	0.55	-0.43	0.38	-0.32	0.03	0.32	0.48		-0.32	0.38	0.2
Roe	0.29	-0.37	-0.81	-0.08	0.31	0.23	-0.12	-0.37	0.31	0.23	0.51	0.5	-0.09	-0.95	0.44	-0.88	0.11	-0.18	0.24	-0.06	-0.16	-0.83	-0.32		-0.18	-0.22
Ev To Operating Cash Flow	-0.84	0.1	0.23	-0.07	-0.54	-0.48	-0.17	0.1	-0.71	-0.41	0.52	-0.71	-0.05	0.26	-0.38	0.16	0.12	1.0	-0.2	0.42	0.94	0.24	0.38	-0.18		0.47
Pe Ratio	-0.53	0.31	0.19	-0.18	-0.46	-0.44	-0.73	0.31	-0.47	-0.23	0.03	-0.15	-0.07	0.17	-0.17	-0.07	0.14	0.47	-0.29	0.89	0.19	0.2	0.2	-0.22	0.47

Click cells to compare fundamentals

Telix Pharmaceuticals Account Relationship Matchups

Telix Pharmaceuticals fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Days Sales Outstanding	51.02	967.02	1.4K	92.09	47.61	45.23
Ev To Sales	0.41	(16.18)	(3.98)	(0.68)	(0.21)	(0.2)
Roic	1.56	(0.54)	(16.03)	(1.08)	0.17	0.18
Inventory Turnover	5.98	3.2	0.74	7.26	10.87	9.24
Days Of Inventory On Hand	61.04	114.15	494.78	50.26	33.58	67.13
Payables Turnover	13.81	0.35	0.21	3.66	5.73	11.12
Sales General And Administrative To Revenue	0.24	3.85	7.13	0.5	0.16	0.15
Capex To Revenue	0.0221	0.0688	0.27	0.0889	0.0217	0.0378
Interest Coverage	(1.7)	(39.8)	(14.42)	(14.37)	1.3	1.36
Days Payables Outstanding	26.44	1.0K	1.7K	99.65	63.7	60.51
Roe	0.8	(0.57)	(37.31)	(1.3)	0.035	0.0367
Return On Tangible Assets	(0.12)	(0.46)	(1.49)	(0.53)	0.0181	0.019
Ev To Free Cash Flow	(1.49)	235.21	14.56	7.64	9.8	10.29
Intangibles To Total Assets	0.0607	0.38	0.51	0.23	0.28	0.29
Net Debt To E B I T D A	2.29	1.81	0.28	1.22	(4.61)	(4.38)
Current Ratio	0.66	4.69	1.25	2.02	1.43	0.9
Receivables Turnover	7.15	0.38	0.25	3.96	7.67	7.06
Debt To Equity	(0.52)	(0.67)	0.0279	1.18	0.13	0.12

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Ptb Ratio
Days Sales Outstanding	Book Value Per Share
Free Cash Flow Yield	Invested Capital
Operating Cash Flow Per Share	Average Payables
Stock Based Compensation To Revenue	Capex To Depreciation
Pb Ratio	Ev To Sales
Free Cash Flow Per Share	Roic
Inventory Turnover	Net Income Per Share
Days Of Inventory On Hand	Payables Turnover
Sales General And Administrative To Revenue	Average Inventory
Research And Ddevelopement To Revenue	Capex To Revenue
Cash Per Share	Pocfratio
Interest Coverage	Payout Ratio
Capex To Operating Cash Flow	Pfcf Ratio
Days Payables Outstanding	Net Current Asset Value
Income Quality	Roe
Tangible Asset Value	Ev To Operating Cash Flow
Pe Ratio	Return On Tangible Assets
Ev To Free Cash Flow	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Dividend Yield	Earnings Yield
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Telix Historical Financial Ratios

About Telix Financial Ratios Analysis

Telix Pharmaceuticals Financial Ratios Chart

Average Payables

Capex To Depreciation

Inventory Turnover

Telix Pharmaceuticals fundamentals Correlations

Telix Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Telix Pharmaceuticals fundamentals Accounts

Also Currently Popular

Additional Tools for Telix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Days Payables Outstanding	+ 1.0	Days Sales Outstanding
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Free Cash Flow Per Share	+ 0.97	Operating Cash Flow Per Share
Operating Cash Flow Per Share	+ 0.95	Free Cash Flow Yield
Pfcf Ratio	+ 0.94	Pocfratio

Roe	- 0.95	Days Of Inventory On Hand
Cash Per Share	- 0.91	Book Value Per Share
Capex To Operating Cash Flow	- 0.9	Capex To Depreciation
Roe	- 0.88	Capex To Revenue
Cash Per Share	- 0.86	Net Income Per Share
Pocfratio	- 0.85	Price To Sales Ratio